Skip to main content
. 2017 Mar 7;8(15):25189–25199. doi: 10.18632/oncotarget.15966

Figure 2.

Figure 2

Kaplan-Meier analysis of overall survival (A) and progression-free survival (B) according to mutation status in the 78 patients with mutation profiling.